BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 599772)

  • 21. [The choice of an adequate method for treating lung cancer taking into account the tumor growth rate].
    Diusembaev ZE
    Med Radiol (Mosk); 1991; 36(11):30-3. PubMed ID: 1658531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive therapeutic response to BCG or to its soluble fraction F70 in some patients with carcinoma of the skin, of the breast or of the larynx.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):43-8. PubMed ID: 944214
    [No Abstract]   [Full Text] [Related]  

  • 23. Skin metastases from primary lung cancer. Report of three cases and a brief review.
    Ardavanis A; Orphanos G; Ioannidis G; Rigatos G
    In Vivo; 2006; 20(5):671-3. PubMed ID: 17091776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary lung cancer. A twenty year experience.
    Eastridge CE; Hughes FA; Greenberg BE
    Med Times; 1968 Oct; 96(10):958-66. PubMed ID: 4300607
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognostic factors in lung cancer based on Shanghai population].
    Liao ML; Gao YT; Yang ZP
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Nocardia rubra cell wall skeleton against pleuritis carcinomatosa in adenocarcinoma of the lung].
    Saijo N; Eguchi K; Tominaga K; Shinkai T; Shimizu E; Shibuya M; Shimabukuro Z; Niitani H
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):290-5. PubMed ID: 6881978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatments and diagnosis of lung cancer--field study results: report from japan lung cancer TNM classification committee].
    Yoshimura K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):708-14. PubMed ID: 6881994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunotherapy and immunochemotherapy of neoplasms-- present status and prospects].
    Saijo N; Niitani H
    Nihon Rinsho; 1981 Apr; 39(4):1874-92. PubMed ID: 6273609
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.
    Yamamura Y; Ogura T; Yoshimoto T; Nishikawa H; Sakatani M
    Gan; 1976 Oct; 67(5):669-77. PubMed ID: 797625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An analysis of the therapeutic effects of 120 cases of lung cancer in the elderly].
    Xu YN
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):321-4, 372. PubMed ID: 3015519
    [No Abstract]   [Full Text] [Related]  

  • 32. Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effects.
    Richman SP; Hersh EM; Gutterman JU; Hortobagyi GN; Blumenschein GR; Rios A; Ribi E
    Cancer Treat Rep; 1981; 65(5-6):383-7. PubMed ID: 7237463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Active specific immunotherapy in patients with lung cancer following tumor removal].
    Mosienko MD; Dorfman MV; Romashko NI
    Vopr Onkol; 1987; 33(3):31-6. PubMed ID: 3494337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
    Cusumano CL; Jernigan JA; Waldman RH
    J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pleural effusion in peripheral cancer of the lung].
    Rybakova NI; Vasilenko VG
    Klin Med (Mosk); 1972 Jun; 50(6):42-6. PubMed ID: 5086275
    [No Abstract]   [Full Text] [Related]  

  • 36. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the therapeutic measures in lung cancer].
    Berëzkin DP; Vagner RI; Ekimov VI; Filatov VN
    Vopr Onkol; 1988; 34(8):936-42. PubMed ID: 2458655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
    Gail MH
    Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pleural effusion in central lung cancer].
    Rybakova NI; Vasilenko VG
    Vestn Akad Med Nauk SSSR; 1972; 27(10):52-7. PubMed ID: 4641122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.